Torrent Pharma raises investment in Torrent Urja to ₹11.88 crore
- Investment in Torrent Urja raised to ₹11.88 crore from ₹7.92 crore
- Stake acquisition set at 26% via cash consideration for Class A shares
- Project involves captive hybrid solar and wind power generation in Gujarat
- Transaction executed as related party deal on arm's length basis
*this image is generated using AI for illustrative purposes only.
Torrent Pharmaceuticals has increased its investment in Torrent Urja 27 Private Limited to ₹11.88 crore to support a captive hybrid power project in Gujarat. The amendment, executed on September 28, 2026, raises the company's equity subscription from ₹7.92 crore to accommodate an expansion in project capacity.
The transaction involves subscribing to 26% of the equity shares of Torrent Urja, a special purpose vehicle formed for setting up the solar and wind energy project. The move aims to enhance the share of renewable power sources in the company's operations and ensure compliance with regulatory requirements for captive users under Indian electricity laws.
Transaction details
The revised investment reflects an increase in the project capacity of the target entity. The consideration is entirely in cash, structured through the purchase of Class A Equity Shares with a face value of ₹10 each.
| Particulars | Details |
|---|---|
| Target Entity | Torrent Urja 27 Private Limited |
| Revised Investment | ₹11.88 crore |
| Previous Investment | ₹7.92 crore |
| Stake Acquired | 26% |
| Share Type | Class A Equity Shares (Face Value ₹10) |
| Completion Timeline | 18 to 21 months |
Strategic rationale and structure
Torrent Urja is currently a wholly owned subsidiary of Torrent Green Energy Private Limited and serves as an associate company of Torrent Pharmaceuticals. The transaction is classified as a related party deal, conducted on an arm's length basis. The entity was incorporated in August 2024 and is yet to commence business operations, reporting nil turnover as on March 31, 2026.
The primary objective is to secure a reliable source of renewable energy for the pharmaceutical major's manufacturing facilities. By increasing its stake, Torrent Pharmaceuticals aligns its capital allocation with its sustainability goals while adhering to the legal frameworks governing captive power consumption in India.
Historical Stock Returns for Torrent Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.40% | +0.60% | -1.28% | +13.30% | +37.87% | 0.0% |
How will the 18-21 month construction timeline impact Torrent Pharmaceuticals' short-term energy cost volatility and operational resilience?
What are the projected long-term savings from this captive hybrid power project compared to current grid tariffs, and how might they influence future capital allocation?
Will the expansion of renewable capacity trigger additional related-party transactions or equity infusions as the project scales beyond its initial phase?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
